COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,536 Articles (22,881 medRxiv, 8,655 bioRxiv)

Most recent first Previous |  Page 1183: Articles 11821-11830  | Next

Multi-ethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes
Jun, T., Mathew, D., Sharma, N., Nirenberg, S., Huang, H.-H., Kovatch, P., Wherry, E. J., Huang, K.-l.
10.1101/2021.10.29.21265687 — Posted: 2021-10-30
Contributions of occupation characteristics and educational attainment to racial/ethnic inequities in COVID-19 mortality
Matthay, E. C., Duchowny, K. A., Riley, A. R., Thomas, M., Chen, Y.-H., Bibbins-Domingo, K., Glymour, M. M. M.
10.1101/2021.10.29.21265628 — Posted: 2021-10-30
Assessment of the fatality rate and transmissibility taking account of undetected cases during an unprecedented COVID-19 surge in Taiwan
Yuan, H.-Y., Hossain, M. P., Wen, T.-H., Wang, M.-J.
10.1101/2021.10.29.21265691 — Posted: 2021-10-30
COVID-19 Advanced Respiratory Care Educational Training Program for Healthcare Workers in Lesotho: An Observational Study
Osula, V., Sanders, J. E., Chakare, T., Mapota-Masoabi, L., Ranyali-Otubanjo, M., Hansoti, B., McCollum, E. D.
10.1101/2021.10.22.21265385 — Posted: 2021-10-30
COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines
Amit, A. M. L., Pepito, V. C. F., Sumpaico-Tanchanco, L., Dayrit, M. M.
10.1101/2021.10.14.21264837 — Posted: 2021-10-30
Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
Kato, H., Miyakawa, K., Ohtake, N., Yamaoka, Y., Yajima, S., Yamazaki, E., Shimada, T., Goto, A., Nakajima, H., Ryo, A.
10.1101/2021.10.30.21265693 — Posted: 2021-10-30
A Multiplex PCR Assay for Identifying All Major SARS-CoV-2 Variants
Dikdan, R. J., Marras, S. A. E., Field, A. P., Brownlee, A., Cironi, A., Hill, D. A., Tyagi, S.
10.1101/2021.10.28.21263107 — Posted: 2021-10-30
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
Naz-McLean, S. A., Kim, A., Zimmer, A., Laibinis, H., Lapan, J., Tyman, P., Hung, J., Kelly, C., Nagireddy, H., Narayanan-Pandit, S., McCarthy, M., Ratnaparkhi, S., Rutherford, H., Patel, R., Dryden-Peterson, S., Hung, D., Woolley, A. E., Cosimi, L. A.
10.1101/2021.10.28.21265624 — Posted: 2021-10-30
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
Mok, C. K. P., Hui, D. S.
10.1101/2021.10.28.21265635 — Posted: 2021-10-30
Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 Variants
Di Germanio, C., Simmons, G., Thorbrogger, C., Martinelli, R., Stone, M., Gniadek, T., Busch, M. P.
10.1101/2021.10.28.21265622 — Posted: 2021-10-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).